Diabetes Mellitus Induced by Nivolumab Plus Regorafenib in a Patient with Esophageal Cancer
Journal of Cancer Research and Practice（2024）
关键词
combine therapy,diabetes mellitus,immune-checkpoint inhibitor,immune-related adverse event,nivolumab,regorafenib,target therapy,thyroiditis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要